Comparing Bictegravir / Emtricitabine / Tenofovir Alafenamide vs Genvoya
| Bictegravir / emtricitabine / tenofovir alafenamide | Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) |
|
|---|
| Bictegravir / emtricitabine / tenofovir alafenamide | Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for HIV Infection. Bictegravir / emtricitabine / tenofovir alafenamide may also be used for purposes not listed in this medication guide. |
Prescription only
Genvoya is a combination antiviral medication that also includes a pharmacokinetic enhancer that can be used to treat people and children with HIV-1 who meet certain criteria. It is 84% to 93%... View more |
||||||||
| More about Bictegravir / emtricitabine / tenofovir alafenamide | More about Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide) | ||||||||
| Ratings & Reviews | |||||||||
|
Bictegravir / emtricitabine / tenofovir alafenamide has an average rating of 7.2 out of 10 from a total of 223 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 19% reported a negative effect. |
Genvoya has an average rating of 7.2 out of 10 from a total of 129 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Bictegravir / emtricitabine / tenofovir alafenamide side effects |
View all Genvoya side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Genvoya prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Biktarvy |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
180 hours |
17 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 443 drugs are known to interact with Bictegravir / emtricitabine / tenofovir alafenamide:
|
A total of 700 drugs are known to interact with Genvoya:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
February 07, 2018 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.